Shearman And Sterling

coronavirus, COVID-19

Jun 15, 2020

The Corporate Executive Features ‘The Impact of COVID-19 on Executive Compensation’

Subscribe

Jump to...

 

THE CORPORATE EXECUTIVE FEATURES ‘THE IMPACT OF COVID-19 ON EXECUTIVE COMPENSATION’

Partners Doreen E. Lilienfeld, John J. Cannon III and Gillian Emmett Moldowan, Of Counsel Linda Rappaport, and associates Matthew Behrens and Desta Hailu authored “The Impact of COVID-19 on Executive Compensation,” which discusses the impact of COVID-19 on annual equity grants, including the effect of the crisis on issues such as grant timing, grant pricing, long-term incentive targets, repricing, sell-to-cover transactions and employee messaging.

The COVID-19 pandemic had a swift and volatile impact on business operations and the financial markets. The crisis arising from COVID-19 and the efforts taken to prevent its spread occurred simultaneously with the annual incentive award cycle of many companies, forcing companies to address incentive setting and employee retention in a rapidly changing environment.

Read “The Impact of COVID-19 on Executive Compensation.”

Authors and Contributors

Doreen E. Lilienfeld

Partner

Compensation, Governance & ERISA

+1 212 848 7171

+1 212 848 7171

+1 650 838 3804

+1 650 838 3804

New York

John J. Cannon III

Partner

Compensation, Governance & ERISA

+1 212 848 8159

+1 212 848 8159

New York

Gillian Emmett Moldowan

Partner

Compensation, Governance & ERISA

+1 212 848 5356

+1 212 848 5356

New York

Linda Rappaport

Of Counsel

Compensation, Governance & ERISA

+1 212 848 7004

+1 212 848 7004

New York

Matthew Behrens

Associate

Compensation, Governance & ERISA

+1 212 848 7045

+1 212 848 7045

New York

Desta Hailu

Associate

Compensation, Governance & ERISA

+1 212 848 4911

+1 212 848 4911

New York